000 01471 a2200445 4500
005 20250514192334.0
264 0 _c20040909
008 200409s 0 0 eng d
022 _a0950-9232
024 7 _a10.1038/sj.onc.1207785
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKarasarides, Maria
245 0 0 _aB-RAF is a therapeutic target in melanoma.
_h[electronic resource]
260 _bOncogene
_cAug 2004
300 _a6292-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aBenzenesulfonates
_xtherapeutic use
650 0 4 _aCell Line, Tumor
650 0 4 _aHumans
650 0 4 _aMelanoma
_xdrug therapy
650 0 4 _aNiacinamide
_xanalogs & derivatives
650 0 4 _aPhenylurea Compounds
650 0 4 _aProto-Oncogene Proteins B-raf
650 0 4 _aProto-Oncogene Proteins c-raf
_xantagonists & inhibitors
650 0 4 _aPyridines
_xtherapeutic use
650 0 4 _aSorafenib
700 1 _aChiloeches, Antonio
700 1 _aHayward, Robert
700 1 _aNiculescu-Duvaz, Dan
700 1 _aScanlon, Ian
700 1 _aFriedlos, Frank
700 1 _aOgilvie, Lesley
700 1 _aHedley, Douglas
700 1 _aMartin, Jan
700 1 _aMarshall, Christopher J
700 1 _aSpringer, Caroline J
700 1 _aMarais, Richard
773 0 _tOncogene
_gvol. 23
_gno. 37
_gp. 6292-8
856 4 0 _uhttps://doi.org/10.1038/sj.onc.1207785
_zAvailable from publisher's website
999 _c14914173
_d14914173